Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Thank you for standing by and welcome to Heron Therapeutics ...

Earlier, I spoke about VAN. And the Nopain Act, both of which will have an impact in 2025. Right now. We are seeing early results that the Crosslink partnership is beginning to drive growth. Our team ...

Reported positive YTD 2024 Adjusted EBITDA of $1.4 million Company expects Q4 2024 Net Revenue in the range of $37 million - $43 million ZYNRELEF® (bupivacaine ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 33.41% ...

根据最近的SEC文件显示，Weave Communications, Inc. (NYSE:WEAV)的主要股东Crosslink Capital Inc.已出售该公司125,000股股票。这些股票以平均价格13.99美元出售，交易总额约为175万美元。此次出售发生在2024年11月6日，交易完成后Crosslink持有的Weave Communications股份约为790万股。